Cadrenal Therapeutics is a late-stage biopharmaceutical company developing novel therapies for life-threatening immune and thrombotic conditions. Its lead candidate, CAD-1005, is a first-in-class selective 12-LOX inhibitor for heparin-induced thrombocytopenia (HIT), with Phase 1 and Phase 2 data and an End-of-Phase 2 FDA meeting completed. Its pipeline also includes tecarfarin, an oral vitamin K antagonist for chronic anticoagulation, and frunexian, an IV Factor XIa inhibitor for acute care settings.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001213900-26-036946 | EDGAR | 85K words |
| 2025-03-13 | 2024-12-31 | 0001213900-25-023759 | EDGAR | 85K words |
| 2024-03-11 | 2023-12-31 | 0001213900-24-021133 | EDGAR | 90K words |
| 2023-03-30 | 2022-12-31 | 0001213900-23-024260 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001213900-26-089153 | EDGAR | 23K words |
| 2025-11-10 | 2025-09-30 | 0001213900-25-107816 | EDGAR | 20K words |
| 2025-08-11 | 2025-06-30 | 0001213900-25-073885 | EDGAR | 15K words |
| 2025-05-08 | 2025-03-31 | 0001213900-25-040788 | EDGAR | 14K words |
| 2024-11-07 | 2024-09-30 | 0001213900-24-095393 | EDGAR | 18K words |
| 2024-08-07 | 2024-06-30 | 0001213900-24-066107 | EDGAR | 17K words |
| 2024-05-09 | 2024-03-31 | 0001213900-24-041014 | EDGAR | 14K words |
| 2023-11-09 | 2023-09-30 | 0001213900-23-084937 | EDGAR | 24K words |
| 2023-08-10 | 2023-06-30 | 0001213900-23-065223 | EDGAR | 22K words |
| 2023-05-10 | 2023-03-31 | 0001213900-23-037929 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-31 | 0001213900-26-095394 | EDGAR | 1K words |
| 2026-08-13 | 0001213900-26-089147 | EDGAR | 3K words |
| 2026-07-21 | 0001213900-26-079824 | EDGAR | 2K words |
| 2026-07-17 | 0001213900-26-079176 | EDGAR | 4K words |
| 2026-04-01 | 0001213900-26-038014 | EDGAR | 11K words |
| 2026-03-31 | 0001213900-26-036937 | EDGAR | 2K words |
| 2026-03-12 | 0001213900-26-026646 | EDGAR | 1K words |
| 2026-02-24 | 0001213900-26-019606 | EDGAR | 2K words |
| 2025-12-23 | 0001213900-25-125433 | EDGAR | 1K words |
| 2025-12-16 | 0001213900-25-121932 | EDGAR | 23K words |
89 total filings indexed. 65 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001937993 |
| Ticker | CVKD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cadrenal.com |
| Listed | 2023-01-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CVKD (~200 tokens, structured JSON with cryptographic provenance)